Clinical Neurology research

Aims and Expertise

Our research mainly focuses on multiple sclerosis, an inflammatory demyelinating disease of the central nervous system that affects about 100,000 people in the UK. We have a broad range of expertise in this field, covering disease pathogenesis, pathology, imaging by advanced techniques, experimental disease models, epidemiology, and clinical trials.

Additional areas of research include neuroimmunology and neurodegeneration.

Associate Professor Nikos Evangelou

Research topics

Our research topics in the field of multiple sclerosis include immunopathogenesis (the immune mechanisms that lead to myelin and axonal damage), the study of the role of infections in the aetiology of the disease and its activation; the role of advanced imaging techniques in the study of tissue damage, in vivo detection of pathology, correlation with neuropathology, and differential diagnosis in the clinic; epidemiology, including the role and mechanisms of smoking in susceptibility and clinical progression of MS; the identification of new therapeutic approaches, including immunomodulation, neuroprotection, and remyelination by pharmacological, biological, and cell-based treatments. 

Trials

Group members have participated in pivotal trials that led to the introduction of most drugs currently used in MS, helped establish the principle of some treatments and the basis for combination therapy in multiple sclerosis.

Worms For Immune Regulation in Multiple Sclerosis (WiRMS) trial

Outcomes

Clinical service

Our senior academics have clinical honorary contracts within the NHS, and there is fertile ground for bench-to-bedside and bedside-to-bench translational work. We deliver neurological care to a population of more than 3 million people. The MS clinic is possibly the largest in England.

Visit the NHS Neurology Services in Nottingham.

Publications

Our research has been published in leading journals.

See other publications under the individual profiles of our group members.